Systematic review of the prevalence of gastric intestinal metaplasia and its area-level association with smoking

Gaceta Sanitaria

Volumn 22, Issue 3, 2008, Pages 236-246

  Peleteiro, Bárbara ^a   Bastos, Joana ^a   Barros, Henrique ^a   Lunet, Nuno ^a  

^a University of Porto   (Portugal)

Author keywords

Ecological study; Helicobacter pylori; Intestinal metaplasia; Smoking; Systematic review

Indexed keywords

EID: 45849118249     PISSN: 02139111     EISSN: 15781283     Source Type: Journal    
DOI: 10.1157/13123970     Document Type: Review

References (73)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide. version 1.0. IARC CancerBase No. 5. Lyon: IARC Press; 2001.
2. Lauren PA, Nevalainen TJ. Epidemiology of intestinal and diffuse types of gastric carcinoma. A time-trend study in Finland with comparison between studies from high- and low-risk areas. Cancer. 1993;71:2926-33.
3. Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet. 1975;2:58-60.
4. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030-44.
5. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology. 1998;114:1169-79.
6. Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol. 1999;94:2373-9.
7. Asaka M, Sugiyama T, Nobuta A, Kato M, Takeda H, Graham DY. Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study. Helicobacter. 2001;6:294-9.
8. Xue FB, Xu YY, Wan Y, Pan BR, Ren J, Fan DM. Association of H. pylori infection with gastric carcinoma: a meta analysis. World J Gastroenterol. 2001;7:801-4.
9. Lunet N, Lacerda-Vieira A, Barros H. Fruit and vegetables consumption and gastric cancer: a systematic review and meta-analysis of cohort studies. Nutr Cancer. 2005;53:1-10.
10. Tredaniel J, Boffetta P, Buiatti E, Saracci R, Hirsch A. Tobacco smoking and gastric cancer: review and meta-analysis. Int J Cancer. 1997;72:565-73.
11. Nishino Y, Inoue M, Tsuji I, Wakai K, Nagata C, Mizoue T, et al. Tobacco smoking and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol. 2006;36:800-7.
12. Kato I, Vivas J, Plummer M, López G, Peraza S, Castro D, et al. Environmental factors in Helicobacter pylori-related gastric precancerous lesions in Venezuela. Cancer Epidemiol Biomarkers Prev. 2004;13:468-76.
13. Shousha S, Barrison IG, El-Sayeed W, Khan S, Parkins RA. A study of incidence and relationship of intestinal metaplasia of gastric antrum and gastric metaplasia of duodenum in patients with nonulcer dyspepsia. Dig Dis Sci. 1984;29:311-6.
14. Tatsuta M, Iishi H, Okuda S. Effect of cigarette smoking on extent of acid-secreting area and intestinal metaplasia in the stomach. Dig Dis Sci. 1988;33:23-9.
15. Kneller RW, You WC, Chang YS, Liu WD, Zhang L, Zhao L, et al. Cigarette smoking and other risk factors for progression of precancerous stomach lesions. J Natl Cancer Inst. 1992;84:1261-6.
16. Jedrychowski W, Popiela T, Drews M, Gabryelewicz A, Marlicz K, Misiunia P, et al. Effect of Helicobacter pylori infection, smoking and dietary habits on the occurrence of antrum intestinal metaplasia. Clinico-epidemiological study in Poland. Pol J Pathol. 1999;50:289-95.
17. Russo A, Maconi G, Spinelli P, Felice GD, Eboli M, Andreola S, et al. Effect of lifestyle, smoking, and diet on development of intestinal metaplasia in H. pylori-positive subjects. Am J Gastroenterol. 2001;96:1402-8.
18. Stemmermann GN, Nomura AM, Chyou PH, Hankin J. Impact of diet and smoking on risk of developing intestinal metaplasia of the stomach. Dig Dis Sci. 1990;35:433-8.
19. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000;404:398-402.
20. Camargo MC, Mera R, Correa P, Peek RM Jr, Fontham ET, Goodman KJ, et al. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15:1674-87.
21. Wang P, Xia HH, Zhang JY, Dai LP, Xu XQ, Wang KJ. Association of interleukin-1 gene polymorphisms with gastric cancer: a meta-analysis. Int J Cancer. 2007;120:552-62.
22. Chen A, Li CN, Hsu PI, Lai KH, Tseng HH, Hsu PN, et al. Risks of interleukin-1 genetic polymorphisms and Helicobacter pylori infection in the development of gastric cancer. Aliment Pharmacol Ther. 2004;20:203-11.
23. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst. 2002;94:1680-7.
24. Zambon CF, Basso D, Navaglia F, Belluco C, Falda A, Fogar P, et al. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine. 2005;29:141-52.
25. Van Doorn LJ, Figueiredo C, Megraud F, Pena S, Midolo P, Queiroz DM, et al. Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology. 1999;116:823-30.
26. Bravo LE, van Doom LJ, Realpe JL, Correa P. Virulence-associated genotypes of Helicobacter pylori: do they explain the African enigma? Am J Gastroenterol. 2002;97:2839-42.
27. Thye T, Burchard GD, Nilius M, Muller-Myhsok B, Horstmann RD. Genomewide linkage analysis identifies polymorphism in the human interferon-gamma receptor affecting Helicobacter pylori infection. Am J Hum Genet. 2003;72:448-53.
28. Zhou Y, Li N, Zhuang W, Liu GJ, Wu TX, Yao X, et al. P53 codon 72 polymorphism and gastric cancer: A meta-analysis of the literature. Int J Cancer. 2007;121:1481-6.
29. Fox JG, Beck P, Dangler CA, Whary MT, Wang TC, Shi HN, et al. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat Med. 2000;6:536-42.
30. Mitchell HM, Ally R, Wadee A, Wiseman M, Segal I. Major differences in the IgG subclass response to Helicobacter pylori in the first and third worlds. Scand J Gastroenterol. 2002;37:517-22.
31. Joossens JV, Hill MJ, Elliott P, Stamler R, Lesaffre E, Dyer A, et al. Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. Int J Epidemiol. 1996;25:494-504.
32. Lunet N, Barros H. Helicobacter pylori infection and gastric cancer: facing the enigmas. Int J Cancer. 2003;106:953-60.
33. Lunet N, Barros H. Helicobacter pylori infection and gastric cancer: facing the enigmas (II). Reply to Tokudome et al. Int J Cancer. 2004;112:168-9.
34. Holcombe C. Helicobacter pylori: the African enigma. Gut. 1992;33:429-31.
35. Miwa H, Go MF, Sato N. H. pylori and gastric cancer: the Asian enigma. Am J Gastroenterol. 2002;97:1106-12.
36. Brenner H, Arndt V, Bode G, Stegmaier C, Ziegler H, Stumer T. Risk of gastric cancer among smokers infected with Helicobacter pylori. Int J Cancer. 2002;98:446-9.
37. Peleteiro B, Lunet N, Figueiredo C, Carneiro F, David L, Barros H. Smoking, Helicobacter pylori virulence, and type of intestinal metaplasia in Portuguese males. Cancer Epidemiol Biomarkers Prev. 2007;16:322-6.
38. Diamanti A, Maino C, Niveloni S, Pedreira S, Vázquez H, Smecuol E, et al. Characterization of gastric mucosal lesions in patients with celiac disease: a prospective controlled study. Am J Gastroenterol. 1999;94:1313-9.
39. Xia HH, Kalantar JS, Talley NJ, Wyatt JM, Adams S, Chueng K, et al. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia? Am J Gastroenterol. 2000;95:114-21.
40. Liu Y, Ponsioen CI, Xiao SD, Tytgat GN, Ten Kate FJ. Geographic pathology of Helicobacter pylori gastritis. Helicobacter. 2005;10:107-13.
41. Cassaro M, Rugge M, Gutiérrez O, Leandro G, Graham DY, Genta RM. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol. 2000;95:1431-8.
42. Kyzekove J, Arlt J, Arltova M. Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection? Hepatogastroenterology. 2001;48:594-602.
43. Abdel-Wahab M, Attallah AM, Elshal MF, Eldousoky I, Zalata KR, El-Ghawalby NA, et al. Correlation between endoscopy, histopathology, and DNA flow cytometry in patients with gastric dyspepsia. Hepatogastroenterology. 1996;43:1313-20.
44. Campbell DI, Warren BF, Thomas JE, Figura N, Telford JL, Sullivan PB. The African enigma: low prevalence of gastric atrophy, high prevalence of chronic inflammation in West African adults and children. Helicobacter. 2001;6:263-7.
45. Mysorekar VV, Chitralekha, Dandekar P, Prakash BS. Antral histopathological changes in acid peptic disease associated with Helicobacter pylori. Indian J Pathol Microbiol. 1999;42:427-34.
46. Malekzadeh R, Sotoudeh M, Derakhshan MH, Mikaeli J, Yazdanbod A, Merat S, et al. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clin Pathol. 2004;57:37-42.
47. Gulmann C, Grace A, Leader M, Butler D, Patchett S, Kay E. Adenomatous polyposis coli gene, beta-catenin, and E-cadherin expression in proximal and distal gastric cancers and precursor lesions: an immunohistochemical study using tissue microarrays. Appl Immunohistochem Mol Morphol. 2003;11:230-7.
48. Rugge M, Cassaro M, Leandro G, Baffa R, Avellini C, Bufo P, et al. Helicobacter pylori in promotion of gastric carcinogenesis. Dig Dis Sci. 1996;41:950-5.
49. Guarner J, Herrera-Goepfert R, Mohar A, Sánchez L, Halperin D, Ley C, et al. Gastric atrophy and extent of intestinal metaplasia in a cohort of Helicobacter pylori-infected patients. Hum Pathol. 2001;32:31-5.
50. Fraser AG, Peng SL, Jass JR. Intestinal metaplasia subtypes and Helicobacter pylori infection: a comparison of ethnic groups in New Zealand. J Gastroenterol Hepatol. 1998;13: 560-5.
51. Oluwasola AO, Ogunbiyi JO. Chronic gastritis and Helicobacter pylori infection in University College Hospital Ibadan, Nigeria - a study of 85 fibre optic gastric biopsies. Niger J Med. 2004;13:372-8.
52. Recavarren-Arce S, Ramírez-Ramos A, Gilman RH, Chinga-Alayo E, Watanabe-Yamamoto J, Rodríguez-Ulloa C, et al. Severe gastritis in the Peruvian Andes. Histopathology. 2005;46:374-9.
53. Lee I, Lee H, Kim M, Fukumoto M, Sawada S, Jakate S, et al. Ethnic difference of Helicobacter pylori gastritis: Korean and Japanese gastritis is characterized by male- and antrum-predominant acute foveolitis in comparison with American gastritis. World J Gastroenterol. 2005;11:94-8.
54. Al-Knawy B, Morad N, Jamal A, Mirdad S, Abol Fotouh M, Ahmed ME, et al. Helicobacter pylori and intestinal metaplasia with its subtypes in the gastric antrum in a Saudi population. Scand J Gastroenterol. 1999;34:562-5.
55. Storskrubb T, Aro P, Ronkainen J, Vieth M, Stolte M, Wreiber K, et al. A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current H. pylori infection: a report on histology and H. pylori detection in the general adult population. Scand J Gastroenterol. 2005;40:302-11.
56. Evrensel T, Manavoglu O, Ozyardimci C, Gulten M, Nak SG, Yerci O. Helicobacter pylori and intestinal metaplasia. J Environ Pathol Toxicol Oncol. 1996;15:215-9.
57. Alhomsi MF, Adeyemi EO. Grading Helicobacter pylori gastritis in dyspeptic patients. Comp Immunol Microbiol Infect Dis. 1996;19:147-54.
58. Whiting JL, Sigurdsson A, Rowlands DC, Hallissey MT, Fielding JW. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut. 2002;50:378-81.
59. World Health Organization, 1997. World Health Organization (1997). Tobacco or heath: a global status report. Country profiles by region [cited Accessed July 15 2002]. Available from: http://www.cdc.gov/tobacco/WHO/index.htm
60. National Tobacco Information Online System. National Tobacco Information Online System (NATIONS). Country data [cited Accessed July 15 2002]. Available from: http://apps.nccd.cdc.gov/nations
61. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161-81.
62. Dursun M, Yilmaz S, Yukselen V, Kilinc N, Canoruc F, Tuzcu A. Evaluation of optimal gastric mucosal biopsy site and number for identification of Helicobacter pylori, gastric atrophy and intestinal metaplasia. Hepatogastroenterology. 2004;51:1732-5.
63. Zhang C, Yamada N, Wu YL, Wen M, Matsuhisa T, Matsukura N. Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer. World J Gastroenterol. 2005;11:791-6.
64. Eriksson NK, Farkkila MA, Voutilainen ME, Arkkila PE. The clinical value of taking routine biopsies from the incisura angularis during gastroscopy. Endoscopy. 2005;37:532-6.
65. Piantadosi S. Invited commentary: ecologic biases. Am J Epidemiol. 1994;139:761-4.
66. López AD, Collishaw NE, Piha T. A descriptive model of the cigarette epidemic in developed countries. Tob Control. 1994;3:242-7.
67. Leung WK, Lin SR, Ching JY, To KF, Ng EK, Chan FK, et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut. 2004;53:1244-9.
68. Koizumi Y, Tsubono Y, Nakaya N, Kuriyama S, Shibuya D, Matsuoka H, et al. Cigarette smoking and the risk of gastric cancer: a pooled analysis of two prospective studies in Japan. Int J Cancer. 2004;112:1049-55.
69. McFarlane GA, Wyatt J, Forman D, Lachlan GW. Trends over time in Helicobacter pylori gastritis in Kenya. Eur J Gastroenterol Hepatol. 2000;12:617-21.
70. Louw JA, Kidd MS, Kummer AF, Taylor K, Kotze U, Hanslo D. The relationship between Helicobacter pylori infection, the virulence genotypes of the infecting strain and gastric cancer in the African setting. Helicobacter. 2001;6:268-73.
71. Smith SI, Kirsch C, Oyedeji KS, Arigbabu AO, Coker AO, Bayerdoffer E, et al. Prevalence of Helicobacter pylori vacA, cagA and iceA genotypes in Nigerian patients with duodenal ulcer disease. J Med Microbiol. 2002;51:851-4.
72. Nessa J, Chart H, Owen RJ, Drasar B. Human serum antibody response to Helicobacter pylori whole cell antigen in an institutionalized Bangladeshi population. J Appl Microbiol. 2001;90:68-72.
73. El-Mahdi AM, Patchett SE, Char S, Domizio P, Fedail SS, Kumar PJ. Does CagA contribute to ulcer pathogenesis in a developing country, such as Sudan? Eur J Gastroenterol Hepatol. 1998;10:313-6.